Database study of lenalidomide (Revlimid) in Germany: monitoring off-label use [Monitoring des Off-Label-Use von Lenalidomid (Revlimid) in Deutschland]

Database study of lenalidomide (Revlimid) in Germany: monitoring off-label use [Monitoring des Off-Label-Use von Lenalidomid (Revlimid) in Deutschland]

[english] Background: Lenalidomide, a derivate of thalidomide, in combination with dexamethasone is indicated for the treatment of multiple myeloma in patients who have received at least one prior therapy. In the USA, lenalidomide is also licensed for the treatment of a certain form of myelodysplast...

Full description

Bibliographic Details
Main Authors: Dörks, Michael, Langner, Ingo, Behr, Sigrid, Timmer, Antje, Garbe, Edeltraut
Format: Article
Language:deu
Published: German Medical Science GMS Publishing House 2013-07-01
Series:GMS Medizinische Informatik, Biometrie und Epidemiologie
Subjects:
lenalidomide
off-label use
multiple myeloma
Lenalidomid
Off-Label-Use
multiples Myelom
Online Access:http://www.egms.de/static/en/journals/mibe/2013-9/mibe000140.shtml

Internet

http://www.egms.de/static/en/journals/mibe/2013-9/mibe000140.shtml

Similar Items